c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression
Wendie Wang(Henan University), Shuzhen Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 20
Related Papers
Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro
|Acta Pharmacologica Sinica|2014|46
Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3
|Cancer Research|2011|40
Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
|Molecular Cancer|2010|28
<p>Hsa_circ_0084927 Regulates Cervical Cancer Advancement via Regulation of the miR-634/TPD52 Axis</p>
|Cancer Management and Research|2020|24